Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

BACKGROUND: Bedaquiline (BDQ) is widely used in the treatment of rifampicin-resistant TB (RR-TB). However, resistance to BDQ is now emerging. There are no standardised regimens for BDQ-resistant TB. This study aims to share experience in managing primary BDQ-resistant TB. METHODS: We performed a ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Moe, S., Rekart, M. L., Hernandez, D., Sholpan, A., Ismailov, A., Oluya, M., Bayniyazova, A., Zinaida, T., Nargiza, P., Gomez-Restrepo, C., Sitali, N., Sinha, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171487/
https://www.ncbi.nlm.nih.gov/pubmed/37143220
http://dx.doi.org/10.5588/ijtld.22.0536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171487/
https://www.ncbi.nlm.nih.gov/pubmed/37143220
http://dx.doi.org/10.5588/ijtld.22.0536

Ejemplares similares